Yarrow Bioscience Inc (YARW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$18.50

From 52W high−56.71%

Volume215171.00

Market cap$168.61M

P/E (TTM)—

P/S (TTM)349.8x

Div yield0.04%

Key dataOct 19, 2026

Open

$18.50

From 52W high

−56.71%

Volume

215171.00

Market cap

$168.61M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−7.7x

P/E (TTM)

—

RSI (14)

38.1

MomentumView details →

1D Return

+9.12%

YTD Return

−31.56%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−7.7x

EV/Sales

302.3x

P/S (TTM)

349.8x

P/B (TTM)

7.6x

ProfitabilityView details →

Gross Margin

97.51%

Net Margin

−3881.54%

EBITDA Margin

−3909.34%

ROE (TTM)

−84.80%

ROA (TTM)

−79.26%

Asset Turnover

0.02x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+6.12%

EPS CAGR 3Y

+33.80%

EBITDA YoY

—

MomentumView details →

1D Return

+9.12%

YTD Return

−31.56%

1Y Return

+5.61%

RSI (14)

38.1

vs 50D SMA

−33.07%

vs 200D SMA

−36.62%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

15.26x

Quick Ratio

15.26x

Div Yield

0.04%

Div Rate

$0.01

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$2.14

EPS Surprise

80.55%

Beats (12Q)

1/12

Next Q EPS Est

−$27.50

Avg Surprise (4Q)

80.55%

Rev Surprise

−51.50%

Financials snapshotView financials →

Revenue (TTM)

482000.00

Net Income (TTM)

−18.71M

Op. CF (TTM)

−16.93M

Next earningsNov 5, 2026 →

Latest newsMore news →

No recent news for YARW.

Similar companies

Oramed Pharmaceuticals Inc.ORMP Precision BioSciences, Inc.DTIL NervGen Pharma Corp. Common stockNGEN Whitehawk Therapeutics IncWHWK MediWound Ltd.MDWD Innate Pharma S.A.IPHA Find similar companies →

Latest newsMore news →

No recent news for YARW.